Latest News

  • 25 Mar 2015

    TapImmune to Attend “5th Annual Cancer Immunotherapy: ...

    Please join TapImmune on a live webcast, hosted by MaidStone Life Sciences, on March 26th at 9:00AM, where TapImmune, along with other leading companies, will be discussing various factors in regards to the field of cancer immunotherapy. Please follow the provided link below for the live webcast:...

    more >

  • 19 Mar 2015

    TapImmune Appoints David Laskow-Pooley, CEO of London Pharma...

    SEATTLE, March 19, 2015 – TapImmune Inc. (OTCBB: TPIV) is pleased to announce the appointment of David Laskow-Pooley to the Company’s Board of Directors. David brings 30 years of experience in all aspects of the discovery, development and commercialization of pharmaceutical and...

    more >